By Maggie Fox

Researchers have developed a new, long-acting malaria drug that they believe may help fight one of the world's biggest killers.

The drug, still known by its experimental name "DSM265," can stop the malaria parasite at several stages in its life cycle, the researchers report in the journal Science Translational Medicine. Tests in people have begun.